Cleerly AI-QCT Demonstrates High Agreement with Invasive IVUS in INVICTUS Registry

Cleerly, a leader in AI-based cardiovascular imaging analysis, presented findings from its multicenter INVICTUS registry at the recent European Congress of Radiology (ECR 2026) in Vienna, Austria. The ...
Business Wire

Deciphera Announces Presentation of Analysis of Crossover Population from the INVICTUS Phase 3 Study of QINLOCK™ (ripretinib) in Patients with Fourth-Line Advanced GIST

INVICTUS is a Phase 3 randomized, double-blind, placebo-controlled, international, multicenter clinical study evaluating the safety, tolerability, and efficacy of QINLOCK compared to placebo in ...
Nasdaq

Deciphera Announces Presentation of Analysis of Crossover Population from the INVICTUS Phase 3 Study of QINLOCK™ (ripretinib) in Patients with Fourth-Line Advanced GIST

- Data Featured at the ESMO World Congress on Gastrointestinal Cancer 2020 Virtual Meeting - “The data presented today further reinforce the potential of QINLOCK to provide meaningful clinical benefit ...